William P. Katt

An Oxazole-Based Small-Molecule Stat3 Inhibitor Modulates Stat3 Stability and Processing and Induces Antitumor Cell Effects

Khandaker Siddiquee, Patrick T. Gunning, Matthew P. Glenn et al. · ACS Chemical Biology · 2007 · 184 citations · Full text

Signal Transduction, Signaling Pathway, Activated Stat3 +15

Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer

Michael J. Lukey, Ahmad A. Cluntun, William P. Katt et al. · Cell Reports · 2019 · 102 citations · Full text

Breast Oncology, Dual-gls/gls2 Inhibitor, Gls-selective Inhibitors +17

Dibenzophenanthridines as Inhibitors of Glutaminase C and Cancer Cell Proliferation

William P. Katt, Sekar Ramachandran, Jon W. Erickson et al. · Molecular Cancer Therapeutics · 2012 · 97 citations · Full text

Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism

Qingqiu Huang, Clint A. Stalnecker, Chengliang Zhang et al. · Journal of Biological Chemistry · 2018 · 87 citations · Full text

Design and evaluation of novel glutaminase inhibitors

Lee McDermott, Prema Iyer, Shawn Rimer et al. · Bioorganic & Medicinal Chemistry · 2016 · 72 citations · Full text

Medicine, Rational Drug Design, Pharmacotherapy +4